The professionals at RCC employ cutting-edge techniques to treat the disease of cancer, such as immunotherapy. An exciting form of cancer immunotherapy used at the Rubio Cancer Center is the use of custom vaccines. While people typically think of vaccines as preventative measures, they are now used to boost the immune system to target the invader cells and treat any form of the disease.
Cancer vaccines work by activating T cells, the body’s natural defenses, and training them to recognize the tumor present using the specific antibodies that it makes. To accomplish this, through the patients own blood we are able to isolate antigens and put them together in a petrie dish with the killer cells which then causes an immune response, including antibody production. Antibodies bind to the antigens present on the surface of tumor cells and direct the T cells to attack. In addition, T cells can recognize cancer antigens present inside tumor cells.
The FDA approved the first vaccine for cancer treatment in 2010. Called sipuleucel-T, or Provenge, the treatment can be used to treat some men who have metastatic prostate cancer by stimulating a response to the antigen prostatic acid phosphatase. This antigen is present on the majority of prostate cancer cells.
At Rubio Cancer Center we not only treat prostate cancer, but all types of cancer.
The Rubio Cancer Center has provided a variety of cancer treatment services for more than 30 years.
It is one of the few hospitals in the entire Country of Mexico to be certified to manufacture and administer Cancer Vaccines and Adult Stem Cells for Cancer Patients and those suffering from degenerative conditions. The founder and Medical Director Geronimo Rubio, Sr and Assisant Medical Director Geronimo Rubio Jr. have also received their Regnerative Medicine degrees from FIMBIR.
Immunotherapy is the new treatment that everyone is talking about for Lung Cancer. New medicines have been approved by the FDA for these cancer vaccines. Patients who have been through traditional treatment are delighted for these new vaccines as a ray of hope to reverse cancer.
At Rubio Cancer Center, Immunotherapy has been the signature treatment for 30 years with all types of cancer combined with low dosages of chemotherapy and radiation.Cancer therapies and treatments take a number of forms, all of which must be supplemented with important lifestyle changes to maximize effectiveness. Using Detoxification protocols to get rid of dead cancer cells as well as toxins has been another significant component for Dr. Rubio’s treatment. Along with cancer vaccines we encourage dietary changes for all patients who receive chemotherapy treatments or other forms of radiation therapy, as the radiation used to eradicate cancer need te supplemented with health building protocols.
To maintain the strength and quality of health necessary to continue radiation treatments, a person must replenish damaged proteins while simultaneously flushing out the old cells. Fruit and vegetables, dairy alternatives, and whole grains are just a few staples of a well-rounded chemotherapy diet. Individuals should also focus on foods that are high in protein, such as chicken and salmon. Dietary supplements, particularly omega-3 fatty acid supplements, can further strengthen the body. Patients should discuss dietary regimens, including supplements, with their medical care providers prior to beginning a chemotherapy program.
For more than 30 years, the Rubio Cancer Center has offered a complete, integrated approach to cancer treatment that combines the most effective elements of traditional and alternative treatments. As the founder and medical director of the Rubio Cancer Center, Dr. Geronimo Rubio has long been critical of the degree to which mammograms were being encouraged by the medical community – an opinion that is becoming increasingly validated by modern research.
The problem arises from a long-held misunderstanding about the nature of cancers. In 1977, cancer treatment specialists began advising regular mammograms for women after age 50, while assuming all breast cancers were essentially the same. Continuing with the assumption that a significant period of time passes between tumor growth and metastasis throughout the body, that recommendation was extended to younger women, believing that earlier detection would increase odds of survival.
In 1993, as evidence began showing that early detection had little effect on breast cancer survival rates, the National Institutes of Health withdrew previous recommendations about early screening, but was met with strong opposition. Only in recent years have concerns become more widespread that the consequences of a false positive diagnosis may outweigh the danger of the cancer. Many women who have had breasts removed after discovering abnormal growths are now learning that most such growths are harmless, while radiation treatments may increase their risk of heart disease and lung cancer. There is even speculation that the radiation used in the mammogram itself may inadvertently trigger breast cancer growth.
While breast cancer is still a serious issue – the second deadliest cancer for women in the United States – some women are now choosing to forego screenings if they are determined to have a low risk for the disease. If a woman discovers an unusual growth in the course of her daily routine, it is still highly recommended that she receive an immediate examination, but doctors today are putting much less emphasis on routine screenings than they have in the past.